EVMN Financials

Income Statement
MetricQ1 2026Q4 2025
Revenue
0
0
Cost of Revenue
0
0
Gross Profit
0
0
Operating Expenses
24.0M
-19.4%
29.7M
R&D
17.3M
-15.1%
20.4M
SG&A
6.6M
-28.8%
9.3M
Operating Income
-23954000
+19.4%
-29716000
EBITDA
-23605000
+19.7%
-29390000
Net Income
-21674000
+23.3%
-28273000
EPS (Basic)
$-0.64
EPS (Diluted)
$-0.64
Shares (Diluted)
33.7M
Evommune (EVMN) — Financials